Status:
COMPLETED
Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether patients experience a better quality of life when they have received education about coping strategies for cognitive dysfunction.
Detailed Description
Cancer treatment may consist of chemotherapy, radiation, hormone therapy, surgery or a combination of all disciplines. However, breast cancer therapies have at times demonstrated distressing effects i...
Eligibility Criteria
Inclusion
- Age \>18years old
- Stage 0-IV breast cancer (excluding stage IV with metastasis to the brain)
- Life expectancy \> 3 months
- Able to speak and read English fluently
- Self-reported cognitive difficulties that interfere with everyday activities
- Reported Memory/Cognitive changes on Distress Thermometer
- Able to provide written and informed consent
- Willing to complete FACT-Cog questionnaire
Exclusion
- Current Cognitive Training, for example, use of brain training, physical therapy, occupational or speech therapy for the sole purpose of improving cognitive function
- Recent diagnosis of Major depression or other current psychiatric disorders and are not considered stable per a current care provider
- History of Dementia or Alzheimer's Disease
- History of Central Nervous System (CNS) radiation, intrathecal chemotherapy, or CNS involved surgery
- History of metastatic disease extending to the brain
- History of traumatic brain injury
- History of seizure disorder
- History of thyroid disorder (Subjects that are well managed without changes in thyroid medications or doses for at least 6 months may participate in study)
- Current use of illicit substances and or alcohol (including medical marijuana)
- Current sleep disturbance/disorder (Subjects that are well managed without changes in sleep medications or doses for at least 6 months may participate in study).
- Concurrent use of antidepressants for example, use of antidepressants for pain management or smoking cessation. (Subjects that are well managed without changes on antidepressant medications or doses for at least 6 months may participate in study).
Key Trial Info
Start Date :
November 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT03476226
Start Date
November 18 2017
End Date
September 1 2019
Last Update
October 4 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Advocate Good Shepherd Hospital
Barrington, Illinois, United States, 60010
2
Advocate Illinois Masonic Medical Center
Chicago, Illinois, United States, 60657
3
Advocate Sherman Hospital
Elgin, Illinois, United States, 60123
4
Advocate South Suburban Hospital
Hazel Crest, Illinois, United States, 60429